ArticleMolecular cancer research : MCR2017

A First-in-Class TWIST1 Inhibitor with Activity in Oncogene-Driven Lung Cancer.

Zachary A Yochum et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.